TGFB1 and neoplasm: In the tumor tissue, TGFβ-1 expressions were inhibited in all combination treatment groups when compared with the rAd.sT.GM group, suggesting a stronger blockade of TGFβ-1 mediated pro-tumorigenic signaling in the tumor microenvironment by the combinations (Figure 6H).